Curis
CRIS
#10201
Rank
โ‚ฌ14.99 M
Marketcap
1,16ย โ‚ฌ
Share price
0.00%
Change (1 day)
-68.26%
Change (1 year)

Curis (CRIS) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ7.77 Million

According to Curis's latest financial reports the company has โ‚ฌ7.77 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Curis - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ19.21 M-62.29%
2023-12-31โ‚ฌ50.95 M-36.16%
2022-12-31โ‚ฌ79.82 M-21.99%
2021-12-31โ‚ฌ0.10 B-25.3%
2020-12-31โ‚ฌ0.13 B647.01%
2019-12-31โ‚ฌ18.33 M-13.56%
2018-12-31โ‚ฌ21.21 M-57.74%
2017-12-31โ‚ฌ50.19 M18.7%
2016-12-31โ‚ฌ42.29 M-43.74%
2015-12-31โ‚ฌ75.17 M83.76%
2014-12-31โ‚ฌ40.9 M-2.9%
2013-12-31โ‚ฌ42.12 M0.34%
2012-12-31โ‚ฌ41.98 M44.57%
2011-12-31โ‚ฌ29.04 M-4.85%
2010-12-31โ‚ฌ30.52 M73.18%
2009-12-31โ‚ฌ17.62 M-14.6%
2008-12-31โ‚ฌ20.63 M-27.31%
2007-12-31โ‚ฌ28.39 M2.21%
2006-12-31โ‚ฌ27.78 M-25.56%
2005-12-31โ‚ฌ37.32 M2.24%
2004-12-31โ‚ฌ36.5 M30.04%
2003-12-31โ‚ฌ28.06 M-28.39%
2002-12-31โ‚ฌ39.19 M-33.56%
2001-12-31โ‚ฌ59 M-25.96%
2000-12-31โ‚ฌ79.68 M275.22%
1999-12-31โ‚ฌ21.23 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Exelixis
EXEL
โ‚ฌ0.84 B 10,821.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.21 B 2,612.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚ฌ48.21 M 520.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ0.50 B 6,343.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ12.86 B 165,450.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ14.17 B 182,222.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚ฌ1.53 M-80.19%๐Ÿ‡บ๐Ÿ‡ธ USA